alitretinoin
Term · Oncology and biomedicine · MLC-T-ONC-009769
An orally- and topically-active naturally-occurring retinoic acid with antineoplastic, chemopreventive, teratogenic, and embryotoxic activities. Alitretinoin binds to and activates nuclear retinoic acid receptors (RAR) and retinoid X receptors (RXR); these activated receptors act as transcription factors, regulating gene expression that results in the inhibition of cell proliferation, induction of cell differentiation, and apoptosis of both normal cells and tumor cells.
| Identifier | MLC-T-ONC-009769 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | 9-cRA |
| Synonyms | 9-cis-retinoic acid; 9-cis retinoic acid; retinoicacid-9-cis |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-009769",
"term": "alitretinoin",
"field": "Oncology and biomedicine",
"definition": "An orally- and topically-active naturally-occurring retinoic acid with antineoplastic, chemopreventive, teratogenic, and embryotoxic activities. Alitretinoin binds to and activates nuclear retinoic acid receptors (RAR) and retinoid X receptors (RXR); these activated receptors act as transcription factors, regulating gene expression that results in the inhibition of cell proliferation, induction of cell differentiation, and apoptosis of both normal cells and tumor cells.",
"abbreviation": "9-cRA",
"synonyms": [
"9-cis-retinoic acid",
"9-cis retinoic acid",
"retinoicacid-9-cis"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/alitretinoin/"
}
Record 636 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.